FLX Bio, Inc. is a biotechnology company focused on the discovery and development of novel therapies that will improve and prolong the lives of people with cancer. The company is targeting key cancer pathways with its clinical-stage program, FLX925, and building a pipeline of immuno-oncology oral medicines designed to activate a patient’s own immune system to eradicate cancer.
|
|
|
|
|
1-10 employees
View all FLX Bio employees
|
|
|
IT Services and IT Consulting
|
|
|
+116504899000
|
|
|
South San Francisco, California
|
|
|
Apri
|
The decision makers in FLX Bio are Karen L, Paul Kassner, etc. Click to Find FLX Bio decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.